ABC.L Gross Margin

As of 2025-05-19, the Gross Margin of Abcam PLC (ABC.L) is 71.1%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ABC.L Gross Margin - Historical Value

Date	Value
2021-12-31	71.1%
2021-06-30	71.1%
2020-06-30	69.3%
2019-06-30	70.5%
2018-06-30	69.9%
2017-06-30	70.1%
2016-06-30	70.2%
2015-06-30	70.5%
2014-06-30	70.6%
2013-06-30	70.9%

ABC.L Gross Margin - Peers Comparison

Ticker	Name	Value
ALERS.PA	Eurobio Scientific SA	47.1%
ALNOV.PA	Novacyt SA	32.2%
AZT.OL	Arcticzymes Technologies ASA	94.3%
B8F.DE	Biofrontera AG	80.6%
BAVA.CO	Bavarian Nordic A/S	49.3%
BIO.DE	Biotest AG	30.8%
BIO.MC	Biosearch SA	39.6%
BIO.WA	Bioton SA	31.2%
BIOG B.ST	Biogaia AB	72.4%
BIOPOR.CO	Bioporto A/S	67.7%
BML.WA	Synthaverse SA	5544%
BONEX.ST	Bonesupport Holding AB	92.6%
CIR.L	Circassia Group PLC	6810%
COX.PA	Nicox SA	10000%
DBV.PA	Dbv Technologies SA	83.6%
ERYP.PA	Erytech Pharma SA	7775.2%
HBC.OL	Hofseth Biocare ASA	34.1%
ISOFOL.ST	Isofol Medical AB (publ)	-4773.2%
OASM.ST	Oasmia Pharmaceutical AB	-6845.6%
ONCO.ST	Oncopeptides AB	91.6%
PA8.DE	Paion AG	94.1%
PHARM.AS	Pharming Group NV	88.1%
PROB.ST	Probi AB	35.1%
SANN.SW	Santhera Pharmaceuticals Holding AG	96.9%
TNG.PA	Transgene SA	-701%
VICO.ST	Vicore Pharma Holding AB	197.1%
VITR.ST	Vitrolife AB	59.3%
VLA.PA	Valneva SE	41.9%